Showing results (301-310 of 432) with videos related to

Sort By:
Pageof 44
AIDS Research and Human Retroviruses|April 21, 2006
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patientsAnna Bonjoch, Roger Paredes, Pere Domingo, et al.
The Journal of Antimicrobial Chemotherapy|June 9, 2022
Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched studyDaniel K Nomah, Juliana Reyes-Urueña, Yesika Díaz, et al.
HIV Clinical Trials|March 18, 2015
Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP studyEnric Pedrol, Ana M Caro-Murillo, Manuel A Castaño, et al.
Eclinicalmedicine|August 12, 2022
Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort studyRaquel Martin-Iguacel, Juliana Reyes-Urueña, Andreu Bruguera, et al.
Antiviral Therapy|December 3, 2003
Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitorsEsteban Martínez, Pere Domingo, Esteban Ribera, et al.
HIV Clinical Trials|May 18, 2012
Response to combined antiretroviral therapy according to gender and origin in a cohort of naïve HIV-infected patients: GESIDA-5808 studyJosé A Pérez-Molina, Marta Mora Rillo, Ignacio Suárez-Lozano, et al.
The Journal of Infection|July 16, 2003
Hepatitis C virus and human immunodeficiency virus coinfection in SpainBernardino Roca, Ignacio Suarez, Juan Gonzalez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|October 22, 2011
[Costs and cost effectiveness analysis of preferred GESIDA regimens for initial antiretroviral therapy]Antonio Javier Blasco, José Ramón Arribas, Bonaventura Clotet, et al.
Plos One|December 3, 2014
Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individualsMarta Massanella, Dan Ouchi, Silvia Marfil, et al.
Iscience|October 9, 2023
Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recoveryAlba Sánchez, Graciano García-Pardo, Fréderic Gómez-Bertomeu, et al.
Pageof 44